Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson's disease.

Tsiouris KM, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Artif Intell Med. 2020 Mar;103:101807. doi: 10.1016/j.artmed.2020.101807. Epub 2020 Jan 21.

PMID:
32143804
2.

Designing a mHealth clinical decision support system for Parkinson's disease: a theoretically grounded user needs approach.

Timotijevic L, Hodgkins CE, Banks A, Rusconi P, Egan B, Peacock M, Seiss E, Touray MML, Gage H, Pellicano C, Spalletta G, Assogna F, Giglio M, Marcante A, Gentile G, Cikajlo I, Gatsios D, Konitsiotis S, Fotiadis D.

BMC Med Inform Decis Mak. 2020 Feb 19;20(1):34. doi: 10.1186/s12911-020-1027-1.

3.

Postpartum intracranial hypotension complicated by posterior reversible encephalopathy syndrome: a case report.

Chondrogiorgi M, Zikou AK, Konitsiotis S, Markoula S.

Int J Neurosci. 2020 Feb 18:1-4. doi: 10.1080/00207454.2020.1730365. [Epub ahead of print]

PMID:
32070168
4.

Do Secondary Progressive Multiple Sclerosis patients benefit from Computer- based cognitive neurorehabilitation? A randomized sham controlled trial.

Messinis L, Kosmidis MH, Nasios G, Konitsiotis S, Ntoskou A, Bakirtzis C, Grigoriadis N, Patrikelis P, Panagiotopoulos E, Gourzis P, Malefaki S, Papathanasopoulos P.

Mult Scler Relat Disord. 2020 Jan 7;39:101932. doi: 10.1016/j.msard.2020.101932. [Epub ahead of print]

PMID:
31927200
5.

Quality of Life and Emotional Strain in Caregivers of Patients with Multiple Sclerosis.

Petrikis P, Baldouma A, Katsanos AH, Konitsiotis S, Giannopoulos S.

J Clin Neurol. 2019 Jan;15(1):77-83. doi: 10.3988/jcn.2019.15.1.77.

6.

An Unsupervised Methodology for the Detection of Epileptic Seizures Using EEG Signals: A Multi-Dataset Evaluation.

Tsiouris KM, Konitsiotis S, Markoula S, Koutsouris DD, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:3390-3393. doi: 10.1109/EMBC.2018.8513079.

PMID:
30441115
7.

Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.

Antonini A, Gentile G, Giglio M, Marcante A, Gage H, Touray MML, Fotiadis DI, Gatsios D, Konitsiotis S, Timotijevic L, Egan B, Hodgkins C, Biundo R, Pellicano C; PD_Manager consortium.

Trials. 2018 Sep 14;19(1):492. doi: 10.1186/s13063-018-2767-4.

8.

A Long Short-Term Memory deep learning network for the prediction of epileptic seizures using EEG signals.

Tsiouris ΚΜ, Pezoulas VC, Zervakis M, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Comput Biol Med. 2018 Aug 1;99:24-37. doi: 10.1016/j.compbiomed.2018.05.019. Epub 2018 May 17.

PMID:
29807250
9.

Symptoms and medications change patterns for Parkinson's disease patients stratification.

Valmarska A, Miljkovic D, Konitsiotis S, Gatsios D, Lavrač N, Robnik-Šikonja M.

Artif Intell Med. 2018 Sep;91:82-95. doi: 10.1016/j.artmed.2018.04.010. Epub 2018 May 24.

PMID:
29803610
10.

Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.

Chondrogiorgi M, Astrakas LG, Zikou AK, Weis L, Xydis VG, Antonini A, Argyropoulou MI, Konitsiotis S.

Brain Imaging Behav. 2019 Feb;13(1):232-240. doi: 10.1007/s11682-018-9863-7.

PMID:
29629498
11.

Levodopa-induced dyskinesia in Parkinson's disease: still no proof? A meta-analysis.

Giannakis A, Chondrogiorgi M, Tsironis C, Tatsioni A, Konitsiotis S.

J Neural Transm (Vienna). 2018 Sep;125(9):1341-1349. doi: 10.1007/s00702-018-1841-0. Epub 2018 Jan 19.

PMID:
29352351
12.

Predicting rapid progression of Parkinson's Disease at baseline patients evaluation.

Tsiouris KM, Rigas G, Gatsios D, Antonini A, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3898-3901. doi: 10.1109/EMBC.2017.8037708.

PMID:
29060749
13.

Restless legs syndrome and cerebrovascular/cardiovascular events: Systematic review and meta-analysis.

Katsanos AH, Kosmidou M, Konitsiotis S, Tsivgoulis G, Fiolaki A, Kyritsis AP, Giannopoulos S.

Acta Neurol Scand. 2018 Jan;137(1):142-148. doi: 10.1111/ane.12848. Epub 2017 Sep 25. Review.

PMID:
28948600
14.

PD_Manager: an mHealth platform for Parkinson's disease patient management.

Tsiouris KM, Gatsios D, Rigas G, Miljkovic D, Koroušić Seljak B, Bohanec M, Arredondo MT, Antonini A, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Healthc Technol Lett. 2017 May 23;4(3):102-108. doi: 10.1049/htl.2017.0007. eCollection 2017 Jun.

15.

ALZCARE: an information system for screening, management and tracking of demented patients.

Protopappas V, Tsiouris K, Chondrogiorgi M, Tsironis C, Konitsiotis S, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5364-5367. doi: 10.1109/EMBC.2016.7591939.

PMID:
28269472
16.

Tremor UPDRS estimation in home environment.

Rigas G, Gatsios D, Fotiadis DI, Chondrogiorgi M, Tsironis C, Konitsiotis S, Gentile G, Marcante A, Antonini A.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:3642-3645. doi: 10.1109/EMBC.2016.7591517.

PMID:
28269083
17.

Monitoring of motor and non-motor symptoms of Parkinson's disease through a mHealth platform.

Cancela J, Villanueva Mascato S, Gatsios D, Rigas G, Marcante A, Gentile G, Biundo R, Giglio M, Chondrogiorgi M, Vilzmann R, Konitsiotis S, Antonini A, Arredondo MT, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:663-666. doi: 10.1109/EMBC.2016.7590789.

PMID:
28268415
18.

Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease.

Chondrogiorgi M, Tzarouchi LC, Zikou AK, Astrakas LG, Kosta P, Argyropoulou MI, Konitsiotis S.

Int J Neurosci. 2016;126(5):422-8. doi: 10.3109/00207454.2015.1023437. Epub 2015 Jun 5.

PMID:
26000811
19.

Natalizumab-related progressive multifocal leukoencephalopathy in Greece.

Mitsikostas DD, Mastorodemos V, Tsagournizakis M, Kodounis A, Tsagkaropoulos A, Konitsiotis S, Toulas P, Papadimitriou A, Papadimitriou D, Tavernarakis A, Papadopoulos D.

Mult Scler Relat Disord. 2014 Mar;3(2):203-10. doi: 10.1016/j.msard.2013.08.006. Epub 2013 Sep 24.

PMID:
25878008
20.

Dopamine agonists early monotherapy for the delay of development of levodopa-induced dyskinesias.

Stathis P, Konitsiotis S, Antonini A.

Expert Rev Neurother. 2015 Feb;15(2):207-13. doi: 10.1586/14737175.2015.1001747. Epub 2015 Jan 12. Review.

PMID:
25578445
21.

PERFORM: a system for monitoring, assessment and management of patients with Parkinson's disease.

Tzallas AT, Tsipouras MG, Rigas G, Tsalikakis DG, Karvounis EC, Chondrogiorgi M, Psomadellis F, Cancela J, Pastorino M, Waldmeyer MT, Konitsiotis S, Fotiadis DI.

Sensors (Basel). 2014 Nov 11;14(11):21329-57. doi: 10.3390/s141121329.

22.

Marchiafava-Bignami disease: An acquired callosotomy.

Lakatos A, Kosta P, Konitsiotis S, Zikou AK, Astrakas LG, Argyropoulou MI.

Neurology. 2014 Sep 23;83(13):1219. doi: 10.1212/WNL.0000000000000811. No abstract available.

PMID:
25253877
23.

Venous pulsatile tinnitus due to pseudotumor cerebri syndrome in a young morbid obese female.

Kastanioudakis I, Konitsiotis S, Asproudis I, Ziavra N.

Hippokratia. 2013 Oct;17(4):383. No abstract available.

24.

Clinical characteristics of Parkinson's disease patients in Greece: a multicenter, nation-wide, cross-sectional study.

Konitsiotis S, Bostantjopoulou S, Chondrogiorgi M, Katsarou Z, Tagaris G, Mavromatis I, Ntzani EE, Mentenopoulos G; members of the Greek Parkinson Study Group.

J Neurol Sci. 2014 Aug 15;343(1-2):36-40. doi: 10.1016/j.jns.2014.05.003. Epub 2014 May 11.

PMID:
24950902
25.

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA.

Arthritis Res Ther. 2014 Jun 17;16(3):R125. doi: 10.1186/ar4582.

26.

Dopamine agonist monotherapy in Parkinson's disease and potential risk factors for dyskinesia: a meta-analysis of levodopa-controlled trials.

Chondrogiorgi M, Tatsioni A, Reichmann H, Konitsiotis S.

Eur J Neurol. 2014 Mar;21(3):433-40. doi: 10.1111/ene.12318. Epub 2013 Dec 7.

PMID:
24313869
27.

White matter water diffusion changes in primary Sjögren syndrome.

Tzarouchi LC, Zikou AK, Tsifetaki N, Astrakas LG, Konitsiotis S, Voulgari P, Drosos A, Argyropoulou MI.

AJNR Am J Neuroradiol. 2014 Apr;35(4):680-5. doi: 10.3174/ajnr.A3756. Epub 2013 Nov 1.

28.

Levodopa-induced dyskinesias in Parkinson's disease: emerging treatments.

Bargiotas P, Konitsiotis S.

Neuropsychiatr Dis Treat. 2013;9:1605-17. doi: 10.2147/NDT.S36693. Epub 2013 Oct 22. Review.

29.

Demyelination and other neurological adverse events after anti-TNF therapy.

Kaltsonoudis E, Voulgari PV, Konitsiotis S, Drosos AA.

Autoimmun Rev. 2014 Jan;13(1):54-8. doi: 10.1016/j.autrev.2013.09.002. Epub 2013 Sep 12. Review.

PMID:
24035809
30.

Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.

Ploumis A, Varvarousis D, Konitsiotis S, Beris A.

Disabil Rehabil. 2014;36(4):313-8. doi: 10.3109/09638288.2013.791727. Epub 2013 May 14.

PMID:
23672209
31.

The value of transcranial motor-evoked potentials and free-running electromyography in surgery for cervical disc herniation.

Fotakopoulos G, Alexiou GA, Pachatouridis D, Karagiorgiadis D, Konitsiotis S, Kyritsis AP, Voulgaris S.

J Clin Neurosci. 2013 Feb;20(2):263-6. doi: 10.1016/j.jocn.2012.01.048. Epub 2012 Nov 28.

PMID:
23200113
32.

Automatic detection of freezing of gait events in patients with Parkinson's disease.

Tripoliti EE, Tzallas AT, Tsipouras MG, Rigas G, Bougia P, Leontiou M, Konitsiotis S, Chondrogiorgi M, Tsouli S, Fotiadis DI.

Comput Methods Programs Biomed. 2013 Apr;110(1):12-26. doi: 10.1016/j.cmpb.2012.10.016. Epub 2012 Nov 26.

PMID:
23195495
33.

Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta-analysis.

Stathis P, Smpiliris M, Konitsiotis S, Mitsikostas DD.

Eur J Neurol. 2013 Mar;20(3):527-33. doi: 10.1111/ene.12014. Epub 2012 Nov 12.

PMID:
23145482
34.

An automated methodology for levodopa-induced dyskinesia: assessment based on gyroscope and accelerometer signals.

Tsipouras MG, Tzallas AT, Rigas G, Tsouli S, Fotiadis DI, Konitsiotis S.

Artif Intell Med. 2012 Jun;55(2):127-35. doi: 10.1016/j.artmed.2012.03.003. Epub 2012 Apr 7.

PMID:
22484102
35.

Investigation of the antidyskinetic site of action of metabotropic and ionotropic glutamate receptor antagonists. Intracerebral infusions in 6-hydroxydopamine-lesioned rats with levodopa-induced dyskinesia.

Maranis S, Stamatis D, Tsironis C, Konitsiotis S.

Eur J Pharmacol. 2012 May 15;683(1-3):71-7. doi: 10.1016/j.ejphar.2012.02.036. Epub 2012 Mar 4.

PMID:
22410193
36.

On automated assessment of Levodopa-induced dyskinesia in Parkinson's disease.

Tsipouras MG, Tzallas AT, Fotiadis DI, Konitsiotis S.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:2679-82. doi: 10.1109/IEMBS.2011.6090736.

PMID:
22254893
37.

Assessment of tremor activity in the Parkinson's disease using a set of wearable sensors.

Rigas G, Tzallas AT, Tsipouras MG, Bougia P, Tripoliti EE, Baga D, Fotiadis DI, Tsouli SG, Konitsiotis S.

IEEE Trans Inf Technol Biomed. 2012 May;16(3):478-87. doi: 10.1109/TITB.2011.2182616. Epub 2012 Jan 2.

PMID:
22231198
38.

An emerging problem in clinical practice: how to approach acute psychosis.

Markoula S, Chatzistefanidis D, Konitsiotis S, Kyritsis AP.

Clin Pract. 2011 Dec 30;2(1):e7. doi: 10.4081/cp.2012.e7. eCollection 2012 Jan 1.

39.

Using partial decision trees to predict Parkinson's symptoms: a new approach for diagnosis and therapy in patients suffering from Parkinson's disease.

Exarchos TP, Tzallas AT, Baga D, Chaloglou D, Fotiadis DI, Tsouli S, Diakou M, Konitsiotis S.

Comput Biol Med. 2012 Feb;42(2):195-204. doi: 10.1016/j.compbiomed.2011.11.008. Epub 2011 Dec 23.

PMID:
22197114
40.

Investigation of unmedicated early onset restless legs syndrome by voxel-based morphometry, T2 relaxometry, and functional MR imaging during the night-time hours.

Margariti PN, Astrakas LG, Tsouli SG, Hadjigeorgiou GM, Konitsiotis S, Argyropoulou MI.

AJNR Am J Neuroradiol. 2012 Apr;33(4):667-72. doi: 10.3174/ajnr.A2829. Epub 2011 Dec 15.

41.

CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry.

Tzarouchi LC, Tsifetaki N, Konitsiotis S, Zikou A, Astrakas L, Drosos A, Argyropoulou MI.

AJR Am J Roentgenol. 2011 Nov;197(5):1207-12. doi: 10.2214/AJR.10.5984.

PMID:
22021516
42.

Treatment of motor symptoms in advanced Parkinson's disease: a practical approach.

Maranis S, Tsouli S, Konitsiotis S.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1795-807. doi: 10.1016/j.pnpbp.2011.05.014. Epub 2011 May 30. Review.

PMID:
21645577
43.

Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease.

Stathis P, Konitsiotis S, Tagaris G, Peterson D; VALID-PD Study Group.

Mov Disord. 2011 Feb 1;26(2):264-70. doi: 10.1002/mds.23355. Epub 2010 Dec 13.

PMID:
21412833
44.

Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.

Pappa S, Tsouli S, Apostolou G, Mavreas V, Konitsiotis S.

Clin Neuropharmacol. 2010 Nov-Dec;33(6):271-5.

PMID:
21121175
45.

Automated Levodopa-induced dyskinesia assessment.

Tsipouras MG, Tzallas AT, Rigas G, Bougia P, Fotiadis DI, Konitsiotis S.

Conf Proc IEEE Eng Med Biol Soc. 2010;2010:2411-4. doi: 10.1109/IEMBS.2010.5626130.

PMID:
21095695
46.

How should we treat a patient with early Parkinson's disease?

Tsouli S, Konitsiotis S.

Int J Clin Pract. 2010 Aug;64(9):1210-9. doi: 10.1111/j.1742-1241.2010.02371.x. Review.

PMID:
20653797
47.

Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.

Zintzaras E, Kitsios GD, Papathanasiou AA, Konitsiotis S, Miligkos M, Rodopoulou P, Hadjigeorgiou GM.

Clin Ther. 2010 Feb;32(2):221-37. doi: 10.1016/j.clinthera.2010.01.028. Review.

PMID:
20206780
48.

Akathisia induced by mirtazapine after 20 years of continuous treatment.

Markoula S, Konitsiotis S, Chatzistefanidis D, Lagos G, Kyritsis AP.

Clin Neuropharmacol. 2010 Jan-Feb;33(1):50-1. doi: 10.1097/WNF.0b013e3181bf213b.

PMID:
20124786
49.

Real-time quantification of resting tremor in the Parkinson's disease.

Rigas G, Tzallas AT, Tsalikakis DG, Konitsiotis S, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1306-9. doi: 10.1109/IEMBS.2009.5332580.

PMID:
19963494
50.

Voxel-based morphometry and Voxel-based relaxometry in parkinsonian variant of multiple system atrophy.

Tzarouchi LC, Astrakas LG, Konitsiotis S, Tsouli S, Margariti P, Zikou A, Argyropoulou MI.

J Neuroimaging. 2010 Jul;20(3):260-6. doi: 10.1111/j.1552-6569.2008.00343.x. Epub 2009 Jan 29.

PMID:
19187475

Supplemental Content

Loading ...
Support Center